This is believed to affect molecular processes implicated in the pathophysiology of (chronic) mood disorders related to synaptic plasticity and/or cellular resilience [8], including the enhanced production of brain-derived neurotrophic factor and triggering of the mammalian target of rapamycin (mTOR) signalling [6]. The gene discussed is MTOR; the disease is mood disorder.